Paul Fronstin, director of Health Benefits Research at EBRI, discussed ERISA and trends in employer self-insurance during a ...

ICER to Assess Sanofi’s Tolebrutinib for Secondary Progressive MS ...

ICER to Assess Sanofi’s Tolebrutinib for Secondary Progressive MS ...

ICER to Assess Sanofi’s Tolebrutinib for Secondary Progressive MS ...

ICER to Assess Sanofi’s Tolebrutinib for Secondary Progressive MS ...

ICER to Assess Sanofi’s Tolebrutinib for Secondary Progressive MS ...

ICER to Assess Sanofi’s Tolebrutinib for Secondary Progressive MS ...

ICER to Assess Sanofi’s Tolebrutinib for Secondary Progressive MS ...

ICER to Assess Sanofi’s Tolebrutinib for Secondary Progressive MS ...

ICER to Assess Sanofi’s Tolebrutinib for Secondary Progressive MS ...

The Stanford medical school professor, the expected pick for the top job at the National Institutes of Health, has been a ...

New data suggests clinicians may be slower to recognize sepsis in people with pulmonary arterial hypertension.